1. Home
  2. SLRC vs EVO Comparison

SLRC vs EVO Comparison

Compare SLRC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SLR Investment Corp.

SLRC

SLR Investment Corp.

HOLD

Current Price

$14.16

Market Cap

803.0M

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.41

Market Cap

821.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLRC
EVO
Founded
2007
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
803.0M
821.2M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
SLRC
EVO
Price
$14.16
$2.41
Analyst Decision
Hold
Strong Buy
Analyst Count
7
1
Target Price
$15.36
$7.00
AVG Volume (30 Days)
334.5K
108.5K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
11.45%
N/A
EPS Growth
N/A
N/A
EPS
1.70
N/A
Revenue
N/A
N/A
Revenue This Year
$1.09
N/A
Revenue Next Year
N/A
$7.13
P/E Ratio
$8.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.64
$2.31
52 Week High
$17.26
$4.80

Technical Indicators

Market Signals
Indicator
SLRC
EVO
Relative Strength Index (RSI) 41.52 28.78
Support Level $13.95 $2.31
Resistance Level $15.52 $3.78
Average True Range (ATR) 0.29 0.09
MACD -0.01 -0.04
Stochastic Oscillator 32.98 9.98

Price Performance

Historical Comparison
SLRC
EVO

About SLRC SLR Investment Corp.

SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: